A detailed history of Barclays PLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 6,395 shares of ASRT stock, worth $5,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,395
Previous 6,395 -0.0%
Holding current value
$5,435
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$1.07 - $1.75 $21,958 - $35,913
-20,522 Reduced 76.24%
6,395 $8,000
Q2 2024

Aug 14, 2024

SELL
$0.75 - $1.31 $31,963 - $55,829
-42,618 Reduced 61.29%
26,917 $33,000
Q1 2024

May 15, 2024

SELL
$0.79 - $1.14 $47,031 - $67,868
-59,534 Reduced 46.13%
69,535 $67,000
Q4 2023

Feb 15, 2024

BUY
$1.02 - $2.57 $108,200 - $272,623
106,079 Added 461.41%
129,069 $139,000
Q3 2023

Nov 07, 2023

BUY
$2.52 - $5.69 $14,081 - $31,795
5,588 Added 32.11%
22,990 $59,000
Q2 2023

Aug 03, 2023

SELL
$5.0 - $7.66 $544,275 - $833,829
-108,855 Reduced 86.22%
17,402 $95,000
Q1 2023

May 04, 2023

BUY
$3.54 - $6.66 $446,949 - $840,871
126,257 New
126,257 $805,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $41M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.